Searching journal content for acromegaly (as phrase) in full text.

Displaying results 1-10 of 117
For checked items
  1. Thematic Review:
    • Rami Alrezk,
    • Fady Hannah-Shmouni,
    • and Constantine A Stratakis
    MEN4 and CDKN1B mutations: the latest of the MEN syndromes Endocr Relat Cancer 24 (10) T195-T208, doi:10.1530/ERC-17-0243 first published on 19 August 2017
    ...acromegaly in the father, severe hypertension (possibly due to endocrine hypertension) in the brother who died at 39  years and MEN1-like features in the proband, who was a 48-year-old Caucasian female with a 3-cm 4i e . ( in . ( .I1 .I1 in ily l. lin l. i e . ( i e . ( i e . ( , a , f ili is , g , ~~~
  2. Editorial:
    • Frank Weber and
    • Lois M Mulligan
    Happy 20th anniversary MEN1: from positional cloning to gene function restoration Endocr Relat Cancer 24 (10) E7-E11, doi:10.1530/ERC-17-0346
    ...acromegaly V. The pathological finding in four autopsied cases of acromegaly with a discussion of their significance. Monograph. New York, NY, USA: Rockefeller Institute for Medical Research. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, L ~~~
  3. Thematic Review:
    • Rachel S van Leeuwaarde,
    • Joanne M de Laat,
    • Carolina R C Pieterman,
    • Koen Dreijerink,
    • Menno R Vriens,
    • and Gerlof D Valk
    The future: medical advances in MEN1 therapeutic approaches and management strategies Endocr Relat Cancer 24 (10) T179-T193, doi:10.1530/ERC-17-0225 first published on 2 August 2017
    ...acromegaly caused by corticotroph and somatotroph adenomas, respectively. Pharmacological treatment of PIT depends on the type of hormone secretion. Treatment for prolactinomas is by dopamine agonists, whereas somatotroph adenomas can be medically treated by somatostatin analogs and the newer growth ~~~
  4. Thematic Review:
    • Sunita K Agarwal
    The future: genetics advances in MEN1 therapeutic approaches and management strategies Endocr Relat Cancer 24 (10) T119-T134, doi:10.1530/ERC-17-0199
    ...acromegaly and germline GPR101 microduplication or mutation occurs in patients with X-linked acrogigantism (X-LAG) (Vierimaa  et  al. 2006, Daly  et  al. 2007, Trivellin  et  al. 2014). Identification of a homozygous germline mutation in the cyclin-dependent kinase inhibitor (CDKI) gene CDKN1B/p27 i ~~~
  5. Research:
    • Patrick Petrossians,
    • Adrian F Daly,
    • Emil Natchev,
    • Luigi Maione,
    • Karin Blijdorp,
    • Mona Sahnoun-Fathallah,
    • Renata Auriemma,
    • Alpha M Diallo,
    • Anna-Lena Hulting,
    • Diego Ferone,
    • Vaclav Hana, Jr,
    • Silvia Filipponi,
    • Caroline Sievers,
    • Claudia Nogueira,
    • Carmen Fajardo-Montañana,
    • Davide Carvalho,
    • Vaclav Hana,
    • Günter K Stalla,
    • Marie-Lise Jaffrain-Réa,
    • Brigitte Delemer,
    • Annamaria Colao,
    • Thierry Brue,
    • Sebastian J C M M Neggers,
    • Sabina Zacharieva,
    • Philippe Chanson,
    • and Albert Beckers
    Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database Endocr Relat Cancer 24 (10) 505-518, doi:10.1530/ERC-17-0253 first published on 21 July 2017
    ...acromegaly at diagnosis 10.1530/ERC-17-0253 Patrick Petrossians1, Adrian F Daly1, Emil Natchev2, Luigi Maione3, Karin Blijdorp4, Mona Sahnoun-Fathallah5, Renata Auriemma6, Alpha M Diallo7, Anna-Lena Hulting8, Diego Ferone9, Vaclav Hana Jr10, Silvia Filipponi11, Caroline Sievers12, Claudia Nogueira13 ~~~
    OPEN ACCESS ARTICLE
  6. Research:
    • Massimo Terzolo,
    • Giuseppe Reimondo,
    • Paola Berchialla,
    • Emanuele Ferrante,
    • Elena Malchiodi,
    • Laura De Marinis,
    • Rosario Pivonello,
    • Silvia Grottoli,
    • Marco Losa,
    • Salvatore Cannavo,
    • Diego Ferone,
    • Marcella Montini,
    • Marta Bondanelli,
    • Ernesto De Menis,
    • Chiara Martini,
    • Efisio Puxeddu,
    • Antonino Velardo,
    • Alessandro Peri,
    • Marco Faustini-Fustini,
    • Patrizia Tita,
    • Francesca Pigliaru,
    • Giulia Peraga,
    • Giorgio Borretta,
    • Carla Scaroni,
    • Nicoletta Bazzoni,
    • Antonio Bianchi,
    • Alessandro Berton,
    • Andreea Liliana Serban,
    • Roberto Baldelli,
    • Letizia Maria Fatti,
    • Annamaria Colao,
    • Maura Arosio,
    • and for the Italian Study Group of Acromegaly
    Acromegaly is associated with increased cancer risk: a survey in Italy Endocr Relat Cancer 24 (9) 495-504, doi:10.1530/ERC-16-0553 first published on 14 July 2017
    ...acromegaly 10.1530/ERC-16-0553 Massimo Terzolo1, Giuseppe Reimondo1, Paola Bhialla2, Emanuele Ferrante3, Elena Malchiodi3, Laura De Marinis4, Rosario Pivonello5, Silvia Grottoli6, Marco Losa7, Salvatore Cannavo8, Diego Ferone9, Marcella Montini10, Marta Bondanelli11, Ernesto De Menis12, Chiara Marti ~~~
  7. Research:
    • R Formosa,
    • J Borg,
    • and J Vassallo
    Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas Endocr Relat Cancer 24 (8) 445-457, doi:10.1530/ERC-17-0112 first published on 25 June 2017
    ...acromegaly ~~~
    OPEN ACCESS ARTICLE
  8. Research:
    • Laura C Hernández-Ramírez,
    • Ryhem Gam,
    • Nuria Valdés,
    • Maya B Lodish,
    • Nathan Pankratz,
    • Aurelio Balsalobre,
    • Yves Gauthier,
    • Fabio R Faucz,
    • Giampaolo Trivellin,
    • Prashant Chittiboina,
    • John Lane,
    • Denise M Kay,
    • Aggeliki Dimopoulos,
    • Stephan Gaillard,
    • Mario Neou,
    • Jérôme Bertherat,
    • Guillaume Assié,
    • Chiara Villa,
    • James L Mills,
    • Jacques Drouin,
    • and Constantine A Stratakis
    Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease Endocr Relat Cancer 24 (8) 379-392, doi:10.1530/ERC-17-0131 first published on 22 May 2017
    ...acromegaly associated with a novel deletion in CDKN1B 5′UTR region. Endocrine 49 58–64. (doi:10.1007/s12020-015-0540-y) Shi Z, Li Z, Li ZJ, Cheng K, Du Y, Fu H & Khuri FR 2015a Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene 34 2538–2545. (doi:10 ~~~
    OPEN ACCESS ARTICLE
  9. Review:
    • Anna Angelousi,
    • Georgios K Dimitriadis,
    • Georgios Zografos,
    • Svenja Nölting,
    • Gregory Kaltsas,
    • and Ashley Grossman
    Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies Endocr Relat Cancer 24 (6) R239-R259, doi:10.1530/ERC-16-0542 first published on 11 April 2017
    ...acromegaly (Colao  et  al. 2014). Pegvisomant, a pegylated analogue of human GH, is currently the only GH-receptor antagonist approved by the FDA available for the treatment of acromegaly. It directly competes for receptor binding with plasma GH resulting in decreased IGF-1 production (van der Lely  ~~~
  10. Review:
    • Georgios K Dimitriadis,
    • Anna Angelousi,
    • Martin O Weickert,
    • Harpal S Randeva,
    • Gregory Kaltsas,
    • and Ashley Grossman
    Paraneoplastic endocrine syndromes Endocr Relat Cancer 24 (6) R173-R190, doi:10.1530/ERC-17-0036 first published on 24 March 2017
    ...acromegaly f hypoglycaemia R174Review G K Dimitriadis et al. Paraneoplastic syndromes DOI: 10.1530/ERC-17-0036 http://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:6 amines or cytokines, or immune cross-reactivity between ne ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. Alert me to new issues of Endocrine-Related Cancer

Most